Showing results (191-200 of 513) with videos related to
Sort By:
Pageof 52
Nature Communications|September 21, 2019
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number loadHyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLCYoujin Kim, Boram Lee, Joon Ho Shim, et al.Nature Communications|February 21, 2020
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicityKwoneel Kim, Hong Sook Kim, Jeong Yeon Kim, et al.Korean Journal of Radiology|November 18, 2015
Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR ImagingEun Kyoung Lee, Seung Hong Choi, Tae Jin Yun, et al.Journal of Neuro-Oncology|June 1, 2015
Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomasByung Sup Kim, Sung Kwon Kim, Seung Hong Choi, et al.European Journal of Cancer (Oxford, England : 1990)|September 8, 2019
Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencingHong Sook Kim, Hongui Cha, Jinho Kim, et al.Lung Cancer (Amsterdam, Netherlands)|May 1, 2010
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutationsDong-Wan Kim, Se-Hoon Lee, Jong Seok Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2015
Mechanisms of Acquired Resistance to AZD9291: A Mutation-Selective, Irreversible EGFR InhibitorTae Min Kim, Ahnah Song, Dong-Wan Kim, et al.Journal of Neuro-Oncology|January 30, 2022
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade gliomaYong-Pyo Lee, Hyun Ae Jung, Min-Sang Lee, et al.Nature Cancer|June 3, 2024
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic featuresTian-Gen Chang, Yingying Cao, Hannah J Sfreddo, et al.Pageof 52